VTYX - Ventyx reports preclinical results for anti-obesity drug VTX3232
2024-06-05 16:38:33 ET
More on Ventyx Biosciences
- Ventyx Biosciences, Inc. (VTYX) Q1 2024 Earnings Call Transcript
- Ventyx Pivots To Obesity Amid Transformation
- Ventyx Biosciences gets new operations chief
- Ventyx Biosciences drops 3%, stockholders to sell ~11.17M shares
- Seeking Alpha’s Quant Rating on Ventyx Biosciences